- Home
- FL vs TARS Comparison
FL vs TARS Comparison
Compare FL & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FL
- TARS
- Stock Information
- Founded
- FL 1879
- TARS 2016
- Country
- FL United States
- TARS United States
- Employees
- FL N/A
- TARS N/A
- Industry
- FL Clothing/Shoe/Accessory Stores
- TARS Medicinal Chemicals and Botanical Products
- Sector
- FL Consumer Discretionary
- TARS Health Care
- Exchange
- FL Nasdaq
- TARS Nasdaq
- Market Cap
- FL 2.1B
- TARS 2.0B
- IPO Year
- FL N/A
- TARS 2020
- Fundamental
- Price
- FL $18.19
- TARS $47.84
- Analyst Decision
- FL Hold
- TARS Strong Buy
- Analyst Count
- FL 18
- TARS 6
- Target Price
- FL $25.33
- TARS $56.00
- AVG Volume (30 Days)
- FL 2.7M
- TARS 449.4K
- Earning Date
- FL 03-05-2025
- TARS 02-25-2025
- Dividend Yield
- FL N/A
- TARS N/A
- EPS Growth
- FL N/A
- TARS N/A
- EPS
- FL N/A
- TARS N/A
- Revenue
- FL $8,124,000,000.00
- TARS $129,621,000.00
- Revenue This Year
- FL $1.79
- TARS $921.89
- Revenue Next Year
- FL $2.21
- TARS $85.83
- P/E Ratio
- FL N/A
- TARS N/A
- Revenue Growth
- FL 0.04
- TARS 801.96
- 52 Week Low
- FL $18.04
- TARS $20.08
- 52 Week High
- FL $35.60
- TARS $57.28
- Technical
- Relative Strength Index (RSI)
- FL 36.69
- TARS 39.21
- Support Level
- FL $18.04
- TARS $49.86
- Resistance Level
- FL $20.35
- TARS $53.22
- Average True Range (ATR)
- FL 0.75
- TARS 2.44
- MACD
- FL 0.01
- TARS -0.56
- Stochastic Oscillator
- FL 6.49
- TARS 7.09
About FL Foot Locker Inc.
Foot Locker Inc operates thousands of retail stores throughout the United States, Canada, Europe, Asia, Australia, and New Zealand. It also has a presence in the Middle East. The company mainly sells athletically inspired shoes and apparel. Foot Locker's merchandise comes from only a few suppliers, with Nike providing the majority. Its portfolio of brands, includes Foot Locker, Kids Foot Locker, Champs Sports, WSS, and atmos. The company has omnichannel capabilities to bridge the digital world and physical stores, including order-in-store, buy online and pickup-in-store, and buy online and ship-from-store, as well as e-commerce. It has three operating segments, North America, EMEA, and Asia Pacific.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. It is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.